Literature DB >> 16714335

The epidemic of renal disease--what drives it and what can be done?

William M McClellan.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16714335     DOI： 10.1093/ndt/gfi317

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  ACE inhibition is renoprotective among obese patients with proteinuria.

Authors:  Francesca Mallamaci; Piero Ruggenenti; Annalisa Perna; Daniela Leonardis; Rocco Tripepi; Giovanni Tripepi; Giuseppe Remuzzi; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2011-04-28       Impact factor: 10.121

2.  Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience.

Authors:  Heejung Bang; Madhu Mazumdar; George Newman; Andrew S Bomback; Christie M Ballantyne; Allan S Jaffe; Phyllis A August; Abhijit V Kshirsagar
Journal:  Nephrol Dial Transplant       Date:  2009-03-26       Impact factor: 5.992

3.  Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Authors:  Youli Wang; Kathleen O Heilig; Andrew W Minto; Shenglin Chen; Minghui Xiang; David A Dean; Richard C Geiger; Anthony Chang; Dimitrina D Pravtcheva; Martin Schlimme; Dilip K Deb; Ying Wang; Charles W Heilig
Journal:  Lab Invest       Date:  2009-11-16       Impact factor: 5.662

4.  Should prevention of chronic kidney disease start before pregnancy?

Authors:  Guido Filler; Meera S Rayar; Orlando da Silva; Ilan Buffo; Dion Pepelassis; Ajay P Sharma
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

5.  Low birth weight increases risk for end-stage renal disease.

Authors:  Bjørn Egil Vikse; Lorentz M Irgens; Torbjørn Leivestad; Stein Hallan; Bjarne M Iversen
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

6.  Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial.

Authors:  Iain C Macdougall
Journal:  Trials       Date:  2007-11-13       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.